These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25612864)

  • 21. The metabolic syndrome in older persons.
    Sinclair A; Viljoen A
    Clin Geriatr Med; 2010 May; 26(2):261-74. PubMed ID: 20497845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel component of the metabolic syndrome: the oxidative stress.
    Hopps E; Noto D; Caimi G; Averna MR
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):72-7. PubMed ID: 19747805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes and cardiovascular disease. Introduction.
    Chait A
    Atheroscler Suppl; 2006 Aug; 7(4):1-4. PubMed ID: 16822721
    [No Abstract]   [Full Text] [Related]  

  • 24. Macrovascular complications of metabolic syndrome: an early intervention is imperative.
    Tenenbaum A; Motro M; Schwammenthal E; Fisman EZ
    Int J Cardiol; 2004 Nov; 97(2):167-72. PubMed ID: 15458679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol.
    Gómez-Marcos MA; Recio-Rodríguez JI; Rodríguez-Sánchez E; Castaño-Sánchez Y; de Cabo-Laso A; Sánchez-Salgado B; Rodríguez-Martín C; Castaño-Sánchez C; Gómez-Sánchez L; García-Ortiz L
    BMC Public Health; 2010 Mar; 10():143. PubMed ID: 20298558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
    Misra A; Khurana L
    Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of metabolic syndrome profile on cardiovascular risk.
    Mitu F; Cobzaru R; Leon MM
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):308-14. PubMed ID: 24340509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertriglyceridemia secondary to obesity and diabetes.
    Subramanian S; Chait A
    Biochim Biophys Acta; 2012 May; 1821(5):819-25. PubMed ID: 22005032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metabolic syndrome: "common soil" for diabetes and atherosclerosis. Novel approaches to an integrated therapy].
    Hanefeld M; Metzler W; Köhler C; Schaper F
    Herz; 2006 May; 31(3):246-54; quiz 255. PubMed ID: 16770562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolic vascular syndrome - guide to an individualized treatment.
    Hanefeld M; Pistrosch F; Bornstein SR; Birkenfeld AL
    Rev Endocr Metab Disord; 2016 Mar; 17(1):5-17. PubMed ID: 26956847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
    Després JP
    Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.
    Esser N; Paquot N; Scheen AJ
    Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome in the prevention of cardiovascular diseases and diabetes--still a matter of debate?
    Ma X; Zhu S
    Eur J Clin Nutr; 2013 May; 67(5):518-21. PubMed ID: 23403882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine.
    Dominiczak MH
    Clin Chem Lab Med; 2003 Sep; 41(9):1266-78. PubMed ID: 14598880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Obesity, metabolic syndrome and diabetes: cardiovascular implications and therapy].
    Alegría Ezquerra E; Castellano Vázquez JM; Alegría Barrero A
    Rev Esp Cardiol; 2008 Jul; 61(7):752-64. PubMed ID: 18590648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms for vascular injury in the metabolic syndrome.
    Yamagishi S; Nakamura K; Jinnouchi Y; Takenaka K; Imaizumi T
    Drugs Exp Clin Res; 2005; 31(3):123-9. PubMed ID: 16033251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.
    Oltman CL; Kleinschmidt TL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
    Vascul Pharmacol; 2008 Jan; 48(1):47-53. PubMed ID: 18164667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
    Cannon CP
    Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.